DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Referenz

Glund S, Stangier J, Schmohl M. et al.
Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial.

Lancet 2015;
386: 680-690.

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: